10-K Filing
Filing Information
| Form Type | 10-K |
| Accession Number | 0001356576-21-000028 |
| Period End Date | 20201231 |
| Filing Date | 20210308 |
| Fiscal Year | 2020 |
| Fiscal Period | FY |
| XBRL Instance | supn-20201231_htm.xml |
Filing Contents
This filing contains the following financial statements:
Balance Sheet
70 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Common stock, par value (in dollars per share) |
CommonStockParOrStatedValuePerShare
|
$0.00 | USD | Point-in-time |
| Common stock, par value (in dollars per share) |
CommonStockParOrStatedValuePerShare
|
$0.00 | USD | Point-in-time |
| Cash and cash equivalents |
CashAndCashEquivalentsAtCarryingValue
|
$288.64M | USD | Point-in-time |
| Common stock, shares authorized (in shares) |
CommonStockSharesAuthorized
|
130.00M | shares | Point-in-time |
| Cash and cash equivalents |
CashAndCashEquivalentsAtCarryingValue
|
$181.38M | USD | Point-in-time |
| Common stock, shares authorized (in shares) |
CommonStockSharesAuthorized
|
130.00M | shares | Point-in-time |
| Common stock, shares issued (in shares) |
CommonStockSharesIssued
|
52.87M | shares | Point-in-time |
| Marketable securities |
MarketableSecuritiesCurrent
|
$133.89M | USD | Point-in-time |
| Common stock, shares issued (in shares) |
CommonStockSharesIssued
|
52.87M | shares | Point-in-time |
| Marketable securities |
MarketableSecuritiesCurrent
|
$165.69M | USD | Point-in-time |
| Common stock, shares outstanding (in shares) |
CommonStockSharesOutstanding
|
52.53M | shares | Point-in-time |
| Accounts receivable, net |
AccountsReceivableNetCurrent
|
$87.33M | USD | Point-in-time |
| Common stock, shares outstanding (in shares) |
CommonStockSharesOutstanding
|
52.53M | shares | Point-in-time |
| Accounts receivable, net |
AccountsReceivableNetCurrent
|
$140.88M | USD | Point-in-time |
| Inventories, net |
InventoryNet
|
$48.33M | USD | Point-in-time |
| Inventories, net |
InventoryNet
|
$26.63M | USD | Point-in-time |
| Prepaid expenses and other current assets |
PrepaidExpenseAndOtherAssetsCurrent
|
$18.68M | USD | Point-in-time |
| Prepaid expenses and other current assets |
PrepaidExpenseAndOtherAssetsCurrent
|
$11.61M | USD | Point-in-time |
| Total current assets |
AssetsCurrent
|
$630.42M | USD | Point-in-time |
| Total current assets |
AssetsCurrent
|
$472.64M | USD | Point-in-time |
| Long term marketable securities |
MarketableSecuritiesNoncurrent
|
$591.77M | USD | Point-in-time |
| Long term marketable securities |
MarketableSecuritiesNoncurrent
|
$350.36M | USD | Point-in-time |
| Property and equipment, net |
PropertyPlantAndEquipmentNet
|
$37.82M | USD | Point-in-time |
| Property and equipment, net |
PropertyPlantAndEquipmentNet
|
$17.07M | USD | Point-in-time |
| Intangible assets, net |
IntangibleAssetsNetExcludingGoodwill
|
$24.84M | USD | Point-in-time |
| Intangible assets, net |
IntangibleAssetsNetExcludingGoodwill
|
$364.34M | USD | Point-in-time |
| Goodwill |
Goodwill
|
$77.91M | USD | Point-in-time |
| Goodwill |
Goodwill
|
- | USD | Point-in-time |
| Deferred income taxes |
DeferredIncomeTaxAssetsNet
|
- | USD | Point-in-time |
| Deferred income taxes |
DeferredIncomeTaxAssetsNet
|
$32.06M | USD | Point-in-time |
| Other assets |
OtherAssetsNoncurrent
|
$21.89M | USD | Point-in-time |
| Other assets |
OtherAssetsNoncurrent
|
$43.25M | USD | Point-in-time |
| Total assets |
Assets
|
$1.16B | USD | Point-in-time |
| Total assets |
Assets
|
$1.50B | USD | Point-in-time |
| Accounts payable and accrued liabilities |
AccountsPayableAndAccruedLiabilitiesCurrent
|
$78.93M | USD | Point-in-time |
| Accounts payable and accrued liabilities |
AccountsPayableAndAccruedLiabilitiesCurrent
|
$49.71M | USD | Point-in-time |
| Accrued product returns and rebates |
AccruedProductReturnsAndRebates
|
$126.19M | USD | Point-in-time |
| Accrued product returns and rebates |
AccruedProductReturnsAndRebates
|
$107.63M | USD | Point-in-time |
| Contingent consideration, current portion |
BusinessCombinationContingentConsiderationLiabilityCurrent
|
- | USD | Point-in-time |
| Contingent consideration, current portion |
BusinessCombinationContingentConsiderationLiabilityCurrent
|
$30.90M | USD | Point-in-time |
| Other current liabilities |
OtherLiabilitiesCurrent
|
$9.08M | USD | Point-in-time |
| Other current liabilities |
OtherLiabilitiesCurrent
|
$3.24M | USD | Point-in-time |
| Total current liabilities |
LiabilitiesCurrent
|
$245.11M | USD | Point-in-time |
| Total current liabilities |
LiabilitiesCurrent
|
$160.59M | USD | Point-in-time |
| Convertible notes, net |
ConvertibleLongTermNotesPayable
|
$345.17M | USD | Point-in-time |
| Convertible notes, net |
ConvertibleLongTermNotesPayable
|
$361.75M | USD | Point-in-time |
| Contingent consideration, long term |
BusinessCombinationContingentConsiderationLiabilityNoncurrent
|
$45.80M | USD | Point-in-time |
| Contingent consideration, long term |
BusinessCombinationContingentConsiderationLiabilityNoncurrent
|
- | USD | Point-in-time |
| Operating lease liabilities, long term |
OperatingLeaseLiabilityNoncurrent
|
$28.58M | USD | Point-in-time |
| Operating lease liabilities, long term |
OperatingLeaseLiabilityNoncurrent
|
$30.44M | USD | Point-in-time |
| Deferred income tax liabilities |
DeferredIncomeTaxLiabilitiesNet
|
- | USD | Point-in-time |
| Deferred income tax liabilities |
DeferredIncomeTaxLiabilitiesNet
|
$35.22M | USD | Point-in-time |
| Other liabilities |
OtherLiabilitiesNoncurrent
|
$42.79M | USD | Point-in-time |
| Other liabilities |
OtherLiabilitiesNoncurrent
|
$28.66M | USD | Point-in-time |
| Total liabilities |
Liabilities
|
$564.85M | USD | Point-in-time |
| Total liabilities |
Liabilities
|
$759.24M | USD | Point-in-time |
| Common stock, $0.001 par value; 130,000,000 shares authorized; 52,868,482 and 52,533,348 shares issued and outstanding as of December 31, 2020 and December 31, 2019, respectively |
CommonStockValue
|
$53.00K | USD | Point-in-time |
| Common stock, $0.001 par value; 130,000,000 shares authorized; 52,868,482 and 52,533,348 shares issued and outstanding as of December 31, 2020 and December 31, 2019, respectively |
CommonStockValue
|
$53.00K | USD | Point-in-time |
| Additional paid-in capital |
AdditionalPaidInCapital
|
$388.41M | USD | Point-in-time |
| Additional paid-in capital |
AdditionalPaidInCapital
|
$409.33M | USD | Point-in-time |
| Accumulated other comprehensive earnings, net of tax |
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
$7.42M | USD | Point-in-time |
| Accumulated other comprehensive earnings, net of tax |
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
$8.97M | USD | Point-in-time |
| Retained earnings |
RetainedEarningsAccumulatedDeficit
|
$326.50M | USD | Point-in-time |
| Retained earnings |
RetainedEarningsAccumulatedDeficit
|
$199.55M | USD | Point-in-time |
| Total stockholders equity |
StockholdersEquity
|
$595.43M | USD | Point-in-time |
| Total stockholders equity |
StockholdersEquity
|
$744.86M | USD | Point-in-time |
| Total stockholders equity |
StockholdersEquity
|
$267.48M | USD | Point-in-time |
| Total stockholders equity |
StockholdersEquity
|
$453.02M | USD | Point-in-time |
| Total liabilities and stockholders equity |
LiabilitiesAndStockholdersEquity
|
$1.16B | USD | Point-in-time |
| Total liabilities and stockholders equity |
LiabilitiesAndStockholdersEquity
|
$1.50B | USD | Point-in-time |
Income Statement
54 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Total revenues |
RevenueFromContractWithCustomerExcludingAssessedTax
|
$392.75M | USD | Annual |
| Total revenues |
RevenueFromContractWithCustomerExcludingAssessedTax
|
$408.90M | USD | Annual |
| Total revenues |
RevenueFromContractWithCustomerExcludingAssessedTax
|
$520.40M | USD | Annual |
| Costs of goods sold |
CostOfGoodsAndServicesSold
|
$15.36M | USD | Annual |
| Costs of goods sold |
CostOfGoodsAndServicesSold
|
$16.66M | USD | Annual |
| Costs of goods sold |
CostOfGoodsAndServicesSold
|
$52.46M | USD | Annual |
| Research and development |
ResearchAndDevelopmentExpense
|
$69.10M | USD | Annual |
| Research and development |
ResearchAndDevelopmentExpense
|
$89.21M | USD | Annual |
| Research and development |
ResearchAndDevelopmentExpense
|
$75.96M | USD | Annual |
| Selling, general and administrative |
SellingGeneralAndAdministrativeExpense
|
$153.25M | USD | Annual |
| Selling, general and administrative |
SellingGeneralAndAdministrativeExpense
|
$200.68M | USD | Annual |
| Selling, general and administrative |
SellingGeneralAndAdministrativeExpense
|
$154.70M | USD | Annual |
| Amortization of intangible assets |
AmortizationOfIntangibleAssets
|
$15.70M | USD | Annual |
| Amortization of intangible assets |
AmortizationOfIntangibleAssets
|
$5.19M | USD | Annual |
| Amortization of intangible assets |
AmortizationOfIntangibleAssets
|
$5.18M | USD | Annual |
| Contingent consideration expense |
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
|
- | USD | Annual |
| Contingent consideration expense |
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
|
- | USD | Annual |
| Contingent consideration expense |
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
|
$1.90M | USD | Annual |
| Total costs and expenses |
CostsAndExpenses
|
$346.70M | USD | Annual |
| Total costs and expenses |
CostsAndExpenses
|
$264.45M | USD | Annual |
| Total costs and expenses |
CostsAndExpenses
|
$244.18M | USD | Annual |
| Operating earnings |
OperatingIncomeLoss
|
$173.70M | USD | Annual |
| Operating earnings |
OperatingIncomeLoss
|
$148.57M | USD | Annual |
| Operating earnings |
OperatingIncomeLoss
|
$144.44M | USD | Annual |
| Interest expense |
OtherNonoperatingExpense
|
$23.75M | USD | Annual |
| Interest expense |
OtherNonoperatingExpense
|
$18.11M | USD | Annual |
| Interest expense |
OtherNonoperatingExpense
|
$22.71M | USD | Annual |
| Interest and other income, net |
OtherNonoperatingIncome
|
$18.70M | USD | Annual |
| Interest and other income, net |
OtherNonoperatingIncome
|
$13.84M | USD | Annual |
| Interest and other income, net |
OtherNonoperatingIncome
|
$21.62M | USD | Annual |
| Total other expense |
OtherNonoperatingIncomeExpense
|
$-4.27M | USD | Annual |
| Total other expense |
OtherNonoperatingIncomeExpense
|
$-5.05M | USD | Annual |
| Total other expense |
OtherNonoperatingIncomeExpense
|
$-1.08M | USD | Annual |
| Earnings before income taxes |
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
$140.18M | USD | Annual |
| Earnings before income taxes |
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
$147.49M | USD | Annual |
| Earnings before income taxes |
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
$168.65M | USD | Annual |
| Income tax expense |
IncomeTaxExpenseBenefit
|
$29.18M | USD | Annual |
| Income tax expense |
IncomeTaxExpenseBenefit
|
$41.70M | USD | Annual |
| Income tax expense |
IncomeTaxExpenseBenefit
|
$34.43M | USD | Annual |
| Net earnings |
NetIncomeLoss
|
$110.99M | USD | Annual |
| Net earnings |
NetIncomeLoss
|
$126.95M | USD | Annual |
| Net earnings |
NetIncomeLoss
|
$113.06M | USD | Annual |
| Basic (in dollars per share) |
EarningsPerShareBasic
|
$2.16 | USD | Annual |
| Basic (in dollars per share) |
EarningsPerShareBasic
|
$2.13 | USD | Annual |
| Basic (in dollars per share) |
EarningsPerShareBasic
|
$2.41 | USD | Annual |
| Diluted (in dollars per share) |
EarningsPerShareDiluted
|
$2.05 | USD | Annual |
| Diluted (in dollars per share) |
EarningsPerShareDiluted
|
$2.36 | USD | Annual |
| Diluted (in dollars per share) |
EarningsPerShareDiluted
|
$2.10 | USD | Annual |
| Basic (in shares) |
WeightedAverageNumberOfSharesOutstandingBasic
|
51.99M | shares | Annual |
| Basic (in shares) |
WeightedAverageNumberOfSharesOutstandingBasic
|
52.62M | shares | Annual |
| Basic (in shares) |
WeightedAverageNumberOfSharesOutstandingBasic
|
52.41M | shares | Annual |
| Diluted (in shares) |
WeightedAverageNumberOfDilutedSharesOutstanding
|
53.69M | shares | Annual |
| Diluted (in shares) |
WeightedAverageNumberOfDilutedSharesOutstanding
|
53.82M | shares | Annual |
| Diluted (in shares) |
WeightedAverageNumberOfDilutedSharesOutstanding
|
54.10M | shares | Annual |
Cash Flow Statement
113 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Net earnings |
NetIncomeLoss
|
$126.95M | USD | Annual |
| Net earnings |
NetIncomeLoss
|
$113.06M | USD | Annual |
| Net earnings |
NetIncomeLoss
|
$110.99M | USD | Annual |
| Depreciation and amortization |
DepreciationDepletionAndAmortization
|
$18.14M | USD | Annual |
| Depreciation and amortization |
DepreciationDepletionAndAmortization
|
$7.06M | USD | Annual |
| Depreciation and amortization |
DepreciationDepletionAndAmortization
|
$6.66M | USD | Annual |
| Amortization of deferred financing costs and debt discount |
AmortizationOfFinancingCostsAndDiscounts
|
$16.58M | USD | Annual |
| Amortization of deferred financing costs and debt discount |
AmortizationOfFinancingCostsAndDiscounts
|
$15.71M | USD | Annual |
| Amortization of deferred financing costs and debt discount |
AmortizationOfFinancingCostsAndDiscounts
|
$11.85M | USD | Annual |
| Share-based compensation expense |
ShareBasedCompensation
|
$14.85M | USD | Annual |
| Share-based compensation expense |
ShareBasedCompensation
|
$11.29M | USD | Annual |
| Share-based compensation expense |
ShareBasedCompensation
|
$16.56M | USD | Annual |
| Realized gains from sales of marketable securities |
MarketableSecuritiesRealizedGainLoss
|
$4.35M | USD | Annual |
| Realized gains from sales of marketable securities |
MarketableSecuritiesRealizedGainLoss
|
$301.00K | USD | Annual |
| Realized gains from sales of marketable securities |
MarketableSecuritiesRealizedGainLoss
|
- | USD | Annual |
| Amortization of premium/discount on marketable securities |
InvestmentIncomeNetAmortizationOfDiscountAndPremium
|
$4.03M | USD | Annual |
| Amortization of premium/discount on marketable securities |
InvestmentIncomeNetAmortizationOfDiscountAndPremium
|
$2.89M | USD | Annual |
| Amortization of premium/discount on marketable securities |
InvestmentIncomeNetAmortizationOfDiscountAndPremium
|
$1.67M | USD | Annual |
| Changes in fair value of contingent consideration |
UnrealizedGainLossOnDerivatives
|
- | USD | Annual |
| Changes in fair value of contingent consideration |
UnrealizedGainLossOnDerivatives
|
$-1.90M | USD | Annual |
| Changes in fair value of contingent consideration |
UnrealizedGainLossOnDerivatives
|
- | USD | Annual |
| Other noncash adjustments, net |
OtherNoncashIncomeExpense
|
$-2.23M | USD | Annual |
| Other noncash adjustments, net |
OtherNoncashIncomeExpense
|
$-1.45M | USD | Annual |
| Other noncash adjustments, net |
OtherNoncashIncomeExpense
|
$1.64M | USD | Annual |
| Deferred income tax (benefit) provision |
DeferredIncomeTaxExpenseBenefit
|
$568.00K | USD | Annual |
| Deferred income tax (benefit) provision |
DeferredIncomeTaxExpenseBenefit
|
$-4.17M | USD | Annual |
| Deferred income tax (benefit) provision |
DeferredIncomeTaxExpenseBenefit
|
$-5.83M | USD | Annual |
| Accounts receivable |
IncreaseDecreaseInAccountsReceivable
|
$34.61M | USD | Annual |
| Accounts receivable |
IncreaseDecreaseInAccountsReceivable
|
$35.86M | USD | Annual |
| Accounts receivable |
IncreaseDecreaseInAccountsReceivable
|
$-15.75M | USD | Annual |
| Inventories |
IncreaseDecreaseInInventories
|
$10.12M | USD | Annual |
| Inventories |
IncreaseDecreaseInInventories
|
$969.00K | USD | Annual |
| Inventories |
IncreaseDecreaseInInventories
|
$9.36M | USD | Annual |
| Prepaid expenses and other assets |
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherCurrentAssets
|
$2.86M | USD | Annual |
| Prepaid expenses and other assets |
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherCurrentAssets
|
$2.37M | USD | Annual |
| Prepaid expenses and other assets |
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherCurrentAssets
|
$10.44M | USD | Annual |
| Accrued product returns and rebates |
IncreaseDecreaseInAccruedProductReturnsAndRebates
|
$10.39M | USD | Annual |
| Accrued product returns and rebates |
IncreaseDecreaseInAccruedProductReturnsAndRebates
|
$38.72M | USD | Annual |
| Accrued product returns and rebates |
IncreaseDecreaseInAccruedProductReturnsAndRebates
|
$566.00K | USD | Annual |
| Accounts payable and other liabilities |
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
$-11.68M | USD | Annual |
| Accounts payable and other liabilities |
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
$8.27M | USD | Annual |
| Accounts payable and other liabilities |
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
$4.12M | USD | Annual |
| Net cash provided by operating activities |
NetCashProvidedByUsedInOperatingActivities
|
$143.13M | USD | Annual |
| Net cash provided by operating activities |
NetCashProvidedByUsedInOperatingActivities
|
$138.40M | USD | Annual |
| Net cash provided by operating activities |
NetCashProvidedByUsedInOperatingActivities
|
$128.99M | USD | Annual |
| Sales and maturities of marketable securities |
ProceedsFromSaleAndMaturityOfMarketableSecurities
|
$253.17M | USD | Annual |
| Sales and maturities of marketable securities |
ProceedsFromSaleAndMaturityOfMarketableSecurities
|
$79.83M | USD | Annual |
| Sales and maturities of marketable securities |
ProceedsFromSaleAndMaturityOfMarketableSecurities
|
$378.42M | USD | Annual |
| Acquisition of USWM, net of cash acquired |
PaymentsToAcquireBusinessesNetOfCashAcquired
|
- | USD | Annual |
| Acquisition of USWM, net of cash acquired |
PaymentsToAcquireBusinessesNetOfCashAcquired
|
$298.54M | USD | Annual |
| Acquisition of USWM, net of cash acquired |
PaymentsToAcquireBusinessesNetOfCashAcquired
|
- | USD | Annual |
| Purchases of marketable securities |
PaymentsToAcquireMarketableSecurities
|
$95.89M | USD | Annual |
| Purchases of marketable securities |
PaymentsToAcquireMarketableSecurities
|
$409.71M | USD | Annual |
| Purchases of marketable securities |
PaymentsToAcquireMarketableSecurities
|
$491.65M | USD | Annual |
| Investment in Navitor Pharmaceuticals, Inc. |
PaymentsToAcquireInterestInSubsidiariesAndAffiliates
|
- | USD | Annual |
| Investment in Navitor Pharmaceuticals, Inc. |
PaymentsToAcquireInterestInSubsidiariesAndAffiliates
|
- | USD | Annual |
| Investment in Navitor Pharmaceuticals, Inc. |
PaymentsToAcquireInterestInSubsidiariesAndAffiliates
|
$15.00M | USD | Annual |
| Purchases of property and equipment |
PaymentsToAcquirePropertyPlantAndEquipment
|
$2.74M | USD | Annual |
| Purchases of property and equipment |
PaymentsToAcquirePropertyPlantAndEquipment
|
$3.45M | USD | Annual |
| Purchases of property and equipment |
PaymentsToAcquirePropertyPlantAndEquipment
|
$844.00K | USD | Annual |
| Deferred legal fees |
IncreaseDecreaseInDeferredChargesInvesting
|
$809.00K | USD | Annual |
| Deferred legal fees |
IncreaseDecreaseInDeferredChargesInvesting
|
$241.00K | USD | Annual |
| Deferred legal fees |
IncreaseDecreaseInDeferredChargesInvesting
|
$-1.35M | USD | Annual |
| Net cash used in investing activities |
NetCashProvidedByUsedInInvestingActivities
|
$-34.70M | USD | Annual |
| Net cash used in investing activities |
NetCashProvidedByUsedInInvestingActivities
|
$-157.92M | USD | Annual |
| Net cash used in investing activities |
NetCashProvidedByUsedInInvestingActivities
|
$-413.48M | USD | Annual |
| Proceeds from issuance of convertible notes |
ProceedsFromConvertibleDebt
|
$402.50M | USD | Annual |
| Proceeds from issuance of convertible notes |
ProceedsFromConvertibleDebt
|
- | USD | Annual |
| Proceeds from issuance of convertible notes |
ProceedsFromConvertibleDebt
|
- | USD | Annual |
| Convertible notes issuance financing costs |
PaymentOfFinancingAndStockIssuanceCosts
|
- | USD | Annual |
| Convertible notes issuance financing costs |
PaymentOfFinancingAndStockIssuanceCosts
|
$10.44M | USD | Annual |
| Convertible notes issuance financing costs |
PaymentOfFinancingAndStockIssuanceCosts
|
- | USD | Annual |
| Proceeds from issuance of warrants |
ProceedsFromIssuanceOfWarrants
|
- | USD | Annual |
| Proceeds from issuance of warrants |
ProceedsFromIssuanceOfWarrants
|
$65.69M | USD | Annual |
| Proceeds from issuance of warrants |
ProceedsFromIssuanceOfWarrants
|
- | USD | Annual |
| Proceeds from issuance of common stock |
ProceedsFromIssuanceOfCommonStock
|
$4.36M | USD | Annual |
| Proceeds from issuance of common stock |
ProceedsFromIssuanceOfCommonStock
|
$11.58M | USD | Annual |
| Proceeds from issuance of common stock |
ProceedsFromIssuanceOfCommonStock
|
$3.93M | USD | Annual |
| Payments on finance lease liability |
PurchasesOfConvertibleNoteHedge
|
$92.90M | USD | Annual |
| Payments on finance lease liability |
PurchasesOfConvertibleNoteHedge
|
$802.00K | USD | Annual |
| Payments on finance lease liability |
PurchasesOfConvertibleNoteHedge
|
- | USD | Annual |
| Net cash provided by financing activities |
NetCashProvidedByUsedInFinancingActivities
|
$3.56M | USD | Annual |
| Net cash provided by financing activities |
NetCashProvidedByUsedInFinancingActivities
|
$3.93M | USD | Annual |
| Net cash provided by financing activities |
NetCashProvidedByUsedInFinancingActivities
|
$376.44M | USD | Annual |
| Net change in cash and cash equivalents |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
$-10.87M | USD | Annual |
| Net change in cash and cash equivalents |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
$91.94M | USD | Annual |
| Net change in cash and cash equivalents |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
$107.26M | USD | Annual |
| Cash and cash equivalents at beginning of year |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$288.64M | USD | Point-in-time |
| Cash and cash equivalents at beginning of year |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$181.38M | USD | Point-in-time |
| Cash and cash equivalents at beginning of year |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$192.25M | USD | Point-in-time |
| Cash and cash equivalents at beginning of year |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$100.30M | USD | Point-in-time |
| Cash and cash equivalents at end of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$288.64M | USD | Point-in-time |
| Cash and cash equivalents at end of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$181.38M | USD | Point-in-time |
| Cash and cash equivalents at end of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$192.25M | USD | Point-in-time |
| Cash and cash equivalents at end of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$100.30M | USD | Point-in-time |
| Cash paid for interest on convertible notes |
InterestPaidNet
|
$1.34M | USD | Annual |
| Cash paid for interest on convertible notes |
InterestPaidNet
|
$2.52M | USD | Annual |
| Cash paid for interest on convertible notes |
InterestPaidNet
|
$2.52M | USD | Annual |
| Cash paid for Biscayne acquisition |
PaymentsToAcquireBusinessesGross
|
$15.00M | USD | Annual |
| Cash paid for Biscayne acquisition |
PaymentsToAcquireBusinessesGross
|
- | USD | Annual |
| Cash paid for Biscayne acquisition |
PaymentsToAcquireBusinessesGross
|
- | USD | Annual |
| Income taxes paid |
IncomeTaxesPaidNet
|
$45.43M | USD | Annual |
| Income taxes paid |
IncomeTaxesPaidNet
|
$51.54M | USD | Annual |
| Income taxes paid |
IncomeTaxesPaidNet
|
$34.77M | USD | Annual |
| Contingent consideration liability related to USWM acquisition |
BusinessCombinationContingentConsiderationArrangementsAcquisitionLiability
|
- | USD | Annual |
| Contingent consideration liability related to USWM acquisition |
BusinessCombinationContingentConsiderationArrangementsAcquisitionLiability
|
- | USD | Annual |
| Contingent consideration liability related to USWM acquisition |
BusinessCombinationContingentConsiderationArrangementsAcquisitionLiability
|
$76.70M | USD | Annual |
| Deferred legal fees and fixed assets included in accounts payable and accrued expenses |
NonCashCapitalizedCostOfIntangibleAssets
|
$1.83M | USD | Annual |
| Deferred legal fees and fixed assets included in accounts payable and accrued expenses |
NonCashCapitalizedCostOfIntangibleAssets
|
$213.00K | USD | Annual |
| Deferred legal fees and fixed assets included in accounts payable and accrued expenses |
NonCashCapitalizedCostOfIntangibleAssets
|
$250.00K | USD | Annual |
| Property and equipment additions from utilization of tenant improvement allowance |
PropertyAndEquipmentAdditionsFromUtilizationOfTenantImprovementAllowance
|
- | USD | Annual |
| Property and equipment additions from utilization of tenant improvement allowance |
PropertyAndEquipmentAdditionsFromUtilizationOfTenantImprovementAllowance
|
$10.15M | USD | Annual |
| Property and equipment additions from utilization of tenant improvement allowance |
PropertyAndEquipmentAdditionsFromUtilizationOfTenantImprovementAllowance
|
- | USD | Annual |
Stockholders Equity
23 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Balance |
StockholdersEquity
|
$595.43M | USD | Point-in-time |
| Balance |
StockholdersEquity
|
$744.86M | USD | Point-in-time |
| Balance |
StockholdersEquity
|
$267.48M | USD | Point-in-time |
| Balance |
StockholdersEquity
|
$453.02M | USD | Point-in-time |
| Share-based compensation |
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
$16.56M | USD | Annual |
| Share-based compensation |
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
$14.85M | USD | Annual |
| Share-based compensation |
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
$11.29M | USD | Annual |
| Issuance of common stock in connection with the Companys equity award plans |
StockIssuedDuringPeriodValueNewIssues
|
$4.36M | USD | Annual |
| Issuance of common stock in connection with the Companys equity award plans |
StockIssuedDuringPeriodValueNewIssues
|
$3.93M | USD | Annual |
| Issuance of common stock in connection with the Companys equity award plans |
StockIssuedDuringPeriodValueNewIssues
|
$11.58M | USD | Annual |
| Equity issued on conversion of convertible notes |
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
|
$56.22M | USD | Annual |
| Purchase of convertible note hedges, net of tax |
AdjustmentsToAdditionalPaidInCapitalPurchasesOfConvertibleNoteHedgesNetOfTax
|
$70.14M | USD | Annual |
| Issuance of warrants |
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
|
$65.69M | USD | Annual |
| Net earnings |
NetIncomeLoss
|
$126.95M | USD | Annual |
| Net earnings |
NetIncomeLoss
|
$113.06M | USD | Annual |
| Net earnings |
NetIncomeLoss
|
$110.99M | USD | Annual |
| Unrealized gain (loss) on marketable securities, net of tax |
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
|
$1.56M | USD | Annual |
| Unrealized gain (loss) on marketable securities, net of tax |
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
|
$10.57M | USD | Annual |
| Unrealized gain (loss) on marketable securities, net of tax |
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
|
$-2.41M | USD | Annual |
| Balance |
StockholdersEquity
|
$595.43M | USD | Point-in-time |
| Balance |
StockholdersEquity
|
$744.86M | USD | Point-in-time |
| Balance |
StockholdersEquity
|
$267.48M | USD | Point-in-time |
| Balance |
StockholdersEquity
|
$453.02M | USD | Point-in-time |
Comprehensive Income
12 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Net earnings |
NetIncomeLoss
|
$126.95M | USD | Annual |
| Net earnings |
NetIncomeLoss
|
$113.06M | USD | Annual |
| Net earnings |
NetIncomeLoss
|
$110.99M | USD | Annual |
| Unrealized gain (loss) on marketable securities, net of tax |
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
|
$1.56M | USD | Annual |
| Unrealized gain (loss) on marketable securities, net of tax |
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
|
$10.57M | USD | Annual |
| Unrealized gain (loss) on marketable securities, net of tax |
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
|
$-2.41M | USD | Annual |
| Other comprehensive earnings (loss), net of tax |
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
$-2.41M | USD | Annual |
| Other comprehensive earnings (loss), net of tax |
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
$10.57M | USD | Annual |
| Other comprehensive earnings (loss), net of tax |
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
$1.56M | USD | Annual |
| Comprehensive earnings |
ComprehensiveIncomeNetOfTax
|
$128.51M | USD | Annual |
| Comprehensive earnings |
ComprehensiveIncomeNetOfTax
|
$123.63M | USD | Annual |
| Comprehensive earnings |
ComprehensiveIncomeNetOfTax
|
$108.58M | USD | Annual |
Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.